These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 29532605
1. Hepatitis B virus and risk of non-Hodgkin lymphoma: An updated meta-analysis of 58 studies. Li M, Gan Y, Fan C, Yuan H, Zhang X, Shen Y, Wang Q, Meng Z, Xu D, Tu H. J Viral Hepat; 2018 Aug; 25(8):894-903. PubMed ID: 29532605 [Abstract] [Full Text] [Related]
4. Hepatitis B infection increases the risk of non-Hodgkin lymphoma: a meta-analysis of observational studies. Dalia S, Chavez J, Castillo JJ, Sokol L. Leuk Res; 2013 Sep; 37(9):1107-15. PubMed ID: 23809055 [Abstract] [Full Text] [Related]
12. Serological hepatitis B virus (HBV) activity in patients with HBV infection and B-cell non-Hodgkin's lymphoma. Zhou X, Wuchter P, Egerer G, Kriegsmann M, Kommoss FKF, Witzens-Harig M, Kriegsmann K. Eur J Haematol; 2020 May; 104(5):469-475. PubMed ID: 31961011 [Abstract] [Full Text] [Related]
13. High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin's lymphoma in China. Wang C, Xia B, Ning Q, Zhao H, Yang H, Zhao Z, Wang X, Wang Y, Yu Y, Zhang Y. Ann Hematol; 2018 Mar; 97(3):453-457. PubMed ID: 29188315 [Abstract] [Full Text] [Related]
14. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Engels EA, Cho ER, Jee SH. Lancet Oncol; 2010 Sep; 11(9):827-34. PubMed ID: 20688564 [Abstract] [Full Text] [Related]
17. Use of non-steroidal anti-inflammatory drugs and risk of non-Hodgkin lymphoma: a systematic review and meta-analysis. Ye X, Casaclang N, Mahmud SM. Hematol Oncol; 2015 Dec; 33(4):176-86. PubMed ID: 25345915 [Abstract] [Full Text] [Related]
19. Vitamin D status and risk of non-Hodgkin lymphoma: a meta-analysis. Lu D, Chen J, Jin J. Cancer Causes Control; 2014 Nov; 25(11):1553-63. PubMed ID: 25148916 [Abstract] [Full Text] [Related]